Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
Reports from University of Sheffield advance knowledge in breast cancer therapy
October 4th, 2008
A new study, 'Comparing methods for full versus single technology appraisal: a case study of docetaxel and paclitaxel for early breast cancer,' is now available. "The aim of this study is to compare and contrast the reports of the rapid National Institute for Health and Clinical Excellence (NICE) single technology (STA) process with the full Health Technology Assessment Report (TAR) for the same technologies (docetaxel and paclitaxel for the adjuvant treatment of early breast cancer). Documentary analysis was used to compare three reports," scientists writing in the journal Health Policy report. "A data extraction form was developed to record information on the...
Source: Law & Health Weekly (2008-10-04)
|
